<DOC>
	<DOCNO>NCT00267358</DOCNO>
	<brief_summary>Anorexia cachexia devastate complication late-stage cancer patient strongly associate mortality patient . Activation Ghrelin receptor demonstrate stimulate appetite . RC-1291 HCl , virtue ghrelin like activity Growth Hormone release effect may dual role reversal cancer induce anorexia cachexia . This placebo control study evaluate safety efficacy RC-1291 HCl cancer patient anorexia cachexia .</brief_summary>
	<brief_title>Placebo Controlled , Randomized Safety Efficacy Study RC-1291 Cancer Anorexia/Cachexia .</brief_title>
	<detailed_description />
	<mesh_term>Cachexia</mesh_term>
	<criteria>Communitydwelling patient ≥ 18 year age incurable , histologically diagnosed cancer . Involuntary loss body weight ≥ 5 % within past 6 month Presently hospitalize nursing care facility . Inability increase food intake secondary cause . Liver disease If femalepregnant , breastfeed childbearing potential .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>